Citations (47)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Fathalla Belal, Mohamed Walash, Nahed El-Enany & Sahar Zayed. (2018) Development and Validation of GC-MS and HPLC Methods for the Determination of Simvastatin in Tablets and Human Urine. Analytical Chemistry Letters 8:5, pages 713-726.
Read now
Read now
Terry A Jacobson. (2003) Combination lipid-lowering therapy with statins: safety issues in the postcerivastatin era. Expert Opinion on Drug Safety 2:3, pages 269-286.
Read now
Read now
Mohammed H Moghadasian, GB John Mancini & Jiri J Frohlich. (2000) Pharmacotherapy of hypercholesterolaemia: statins in clinical practice. Expert Opinion on Pharmacotherapy 1:4, pages 683-695.
Read now
Read now
Articles from other publishers (44)
Qianhai Fan, Tingting Gong, Chaonan Zheng, Jessica M. Y. Ng, Jianquan Chen, Cynthia Myers, Harvey Hensley, Tom Curran & Zeng-jie Yang. (2021) Statins repress hedgehog signaling in medulloblastoma with no bone toxicities. Oncogene 40:12, pages 2258-2272.
Crossref
Crossref
Connie B. Newman, David Preiss, Jonathan A. Tobert, Terry A. Jacobson, Robert L. PageIIII, Larry B. Goldstein, Clifford Chin, Lisa R. Tannock, Michael Miller, Geetha Raghuveer, P. Barton Duell, Eliot A. Brinton, Amy Pollak, Lynne T. Braun & Francine K. Welty. (2019) Statin Safety and Associated Adverse Events: A Scientific Statement From the American Heart Association. Arteriosclerosis, Thrombosis, and Vascular Biology 39:2.
Crossref
Crossref
Manal Mehibel, Fernando Ortiz-Martinez, Nadine Voelxen, Amy Boyers, Amy Chadwick, Brian A. Telfer, Wolfgang Mueller-Klieser, Catharine M. West, Susan E. Critchlow, Kaye J. Williams & Ian J. Stratford. (2018) Statin-induced metabolic reprogramming in head and neck cancer: a biomarker for targeting monocarboxylate transporters. Scientific Reports 8:1.
Crossref
Crossref
Natalia Mast, Ilya R. Bederman & Irina A. Pikuleva. (2018) Retinal Cholesterol Content Is Reduced in Simvastatin-Treated Mice Due to Inhibited Local Biosynthesis Albeit Increased Uptake of Serum Cholesterol. Drug Metabolism and Disposition 46:11, pages 1528-1537.
Crossref
Crossref
Pankaj Partani, Saurabh Manaswita Verma & Tausif Monif. (2016) Development and Validation of an LC?MS-MS Method for Determination of Simvastatin and Simvastatin Acid in Human Plasma: Application to a Pharmacokinetic Study. Journal of Chromatographic Science 54:8, pages 1385-1396.
Crossref
Crossref
Emmanuel Eroume A. Egom & Hafsa Hafeez. 2016.
127
168
.
Marija Stojanova Jordanov & Hiba Abou Assi. 2015. Lipid Management. Lipid Management
123
147
.
Jonathan Wagner & J. Steven Leeder. (2012) Pediatric Pharmacogenomics. Pediatric Clinics of North America 59:5, pages 1017-1037.
Crossref
Crossref
Patrizia Gazzerro, Maria Chiara Proto, Giuseppina Gangemi, Anna Maria Malfitano, Elena Ciaglia, Simona Pisanti, Antonietta Santoro, Chiara Laezza & Maurizio Bifulco. (2012) Pharmacological Actions of Statins: A Critical Appraisal in the Management of Cancer. Pharmacological Reviews 64:1, pages 102-146.
Crossref
Crossref
Jeffrey A. Pfefferkorn, John Litchfield, Richard Hutchings, Xue-Min Cheng, Scott D. Larsen, Bruce Auerbach, Mark R. Bush, Chitase Lee, Noe Erasga, Daniel M. Bowles, David C. Boyles, Gina Lu, Catherine Sekerke, Valerie Askew, Jeffrey C. Hanselman, Lisa Dillon, Zhiwu Lin, Andrew Robertson, Karl Olsen, Carine Boustany, Karen Atkinson, Theunis C. Goosen, Vaishali Sahasrabudhe, Jonathan Chupka, David B. Duignan, Bo Feng, Renato Scialis, Emi Kimoto, Yi-An Bi, Yurong Lai, Ayman El-Kattan, Rebecca Bakker-Arkema, Paul Barclay, Erick Kindt, Vu Le, Jaap W. Mandema, Mark Milad, Bradley D. Tait, Robert Kennedy, Bharat K. Trivedi & Mark Kowala. (2011) Discovery of novel hepatoselective HMG-CoA reductase inhibitors for treating hypercholesterolemia: A bench-to-bedside case study on tissue selective drug distribution. Bioorganic & Medicinal Chemistry Letters 21:9, pages 2725-2731.
Crossref
Crossref
Srinivasan Shanmugam, Jae-Kuk Ryu, Sun-Dong Yoo, Han-Gon Choi & Jong-Soo Woo. (2011) Evaluation of Pharmacokinetics of Simvastatin and Its Pharmacologically Active Metabolite from Controlled-Release Tablets of Simvastatin in Rodent and Canine Animal Models. Biomolecules and Therapeutics 19:2, pages 248-254.
Crossref
Crossref
Akihito Ogasawara, Masahiro Utoh, Kazuo Nii, Ayumi Ueda, Takahiro Yoshikawa, Toshiyuki Kume & Koichiro Fukuzaki. (2009) Effect of Oral Ketoconazole on Oral and Intravenous Pharmacokinetics of Simvastatin and Its Acid in Cynomolgus Monkeys. Drug Metabolism and Disposition 37:1, pages 122-128.
Crossref
Crossref
René Schramm, Michael D. Menger, Yves Harder, Rudolf Schmits, Oliver Adam, Gabriele Weitz-Schmidt & Hans-Joachim Schäfers. (2007) Statins inhibit lymphocyte homing to peripheral lymph nodes. Immunology 120:3, pages 315-324.
Crossref
Crossref
G. E. Gutierrez, D. Lalka, I. R. Garrett, G. Rossini & G. R. Mundy. (2006) Transdermal application of lovastatin to rats causes profound increases in bone formation and plasma concentrations. Osteoporosis International 17:7, pages 1033-1042.
Crossref
Crossref
Chunze Li, Raju Subramanian, Sean Yu & Thomayant Prueksaritanont. (2006) ACYL-COENZYME A FORMATION OF SIMVASTATIN IN MOUSE LIVER PREPARATIONS. Drug Metabolism and Disposition 34:1, pages 102-110.
Crossref
Crossref
Thomayant Prueksaritanont, Yue Qiu, Lillian Mu, Kimberly Michel, Janice Brunner, Karen M. Richards & Jiunn H. Lin. (2005) Interconversion Pharmacokinetics of Simvastatin and its Hydroxy Acid in Dogs: Effects of Gemfibrozil. Pharmaceutical Research 22:7, pages 1101-1109.
Crossref
Crossref
Iain P Hargreaves, Andrew J Duncan, Simon J R Heales & John M Land. (2005) The Effect of HMG-CoA Reductase Inhibitors on Coenzyme Q10. Drug Safety 28:8, pages 659-676.
Crossref
Crossref
Raphaele Gerber, Jessica D Ryan & Douglas S Clark. (2004) Cell-based screen of HMG-CoA reductase inhibitors and expression regulators using LC–MS. Analytical Biochemistry 329:1, pages 28-34.
Crossref
Crossref
Toshiyuki Funatsu, Hirotoshi Kakuta, Toshiyuki Takasu, Masahiro Noguchi, Masanori Suzuki & Keiji Miyata. (2003) Experimental model of postprandial hypertriglyceridemia in sucrose-fed rats and the effectiveness of atorvastatin in the model. Metabolism 52:5, pages 609-615.
Crossref
Crossref
Robert Jaster, Peter Brock, Gisela Sparmann, J?rg Emmrich & Stefan Liebe. (2003) Inhibition of pancreatic stellate cell activation by the hydroxymethylglutaryl coenzyme A reductase inhibitor lovastatin. Biochemical Pharmacology 65:8, pages 1295-1303.
Crossref
Crossref
Viroj WiwanitkitMDMD, Danai WangsaturakaMDMD & Oranee TangphaoMDMD. (2002) LDL-cholesterol lowering effect of a generic product of simvastatin compared to simvastatin (Zocor™) in Thai hypercholesterolemic subjects – a randomized crossover study, the first report from Thailand. BMC Clinical Pharmacology 2:1.
Crossref
Crossref
N. Le Goff, J. C. Koffel, S. Vandenschrieck, L. Jung & G. Ubeaud. (2002) Comparison of in vitro hepatic models for the prediction of metabolic interaction between simvastatin and naringenin. European Journal of Drug Metabolism and Pharmacokinetics 27:4, pages 233-241.
Crossref
Crossref
Thomayant Prueksaritanont, Raju Subramanian, Xiaojun Fang, Bennett Ma, Yue Qiu, Jiunn H. Lin, Paul G. Pearson & Thomas A. Baillie. (2002) Glucuronidation of Statins in Animals and Humans: A Novel Mechanism of Statin Lactonization. Drug Metabolism and Disposition 30:5, pages 505-512.
Crossref
Crossref
Raju Subramanian, Xiaojun Fang & Thomayant Prueksaritanont. (2002) Structural Characterization of in Vivo Rat Glutathione Adducts and a Hydroxylated Metabolite of Simvastatin Hydroxy Acid. Drug Metabolism and Disposition 30:3, pages 225-230.
Crossref
Crossref
David Williams & John Feely. (2002) Pharmacokinetic-Pharmacodynamic Drug Interactions with HMG-CoA Reductase Inhibitors. Clinical Pharmacokinetics 41:5, pages 343-370.
Crossref
Crossref
Gabriele Weitz-Schmidt, Karl Welzenbach, Volker Brinkmann, Tetsji Kamata, Joerg Kallen, Christian Bruns, Sylvain Cottens, Yoshikazu Takada & Ulrich Hommel. (2001) Statins selectively inhibit leukocyte function antigen-1 by binding to a novel regulatory integrin site. Nature Medicine 7:6, pages 687-692.
Crossref
Crossref
Alberto Corsini, Stefano Bellosta, Roberta Baetta, Remo Fumagalli, Rodolfo Paoletti & Franco Bernini. (1999) New insights into the pharmacodynamic and pharmacokinetic properties of statins. Pharmacology & Therapeutics 84:3, pages 413-428.
Crossref
Crossref
Mohammed H. Moghadasian. (1999) Clinical pharmacology of 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitors. Life Sciences 65:13, pages 1329-1337.
Crossref
Crossref
DJ Betteridge. (1999) INTERNATIONAL MULTICENTRE COMPARISON OF CERIVASTATIN WITH PLACEBO AND SIMVASTATIN FOR THE TREATMENT OF PATIENTS WITH PRIMARY HYPERCHOLESTEROLAEMIA. International Journal of Clinical Practice 53:4, pages 243-250.
Crossref
Crossref
Duane G. Wombolt, Angela Jackson, Rajesh Punn, Stanley Smith, Thomas R. McCune & Patricia B. Williams. (2013) Case Report: Rhabdomyolysis Induced by Mibefradil in a Patient Treated with Cyclosporine and Simvastatin. The Journal of Clinical Pharmacology 39:3, pages 310-312.
Crossref
Crossref
ANNIE TAN, HÉLÈNE LEVREY, CORNELIA DAHM, VITALY A. POLUNOVSKY, JEFFREY RUBINS & PETER B. BITTERMAN. (1999)
Lovastatin Induces Fibroblast Apoptosis
In Vitro
and
In Vivo
. American Journal of Respiratory and Critical Care Medicine 159:1, pages 220-227.
Crossref
Crossref
Donald B Hunninghake. (1998) Clinical efficacy of cerivastatin: phase IIa dose-ranging and dose-scheduling studies. The American Journal of Cardiology 82:4, pages 26J-31J.
Crossref
Crossref
Michel Farnier & Jean Davignon. (1998) Current and future treatment of hyperlipidemia: the role of statins. The American Journal of Cardiology 82:4, pages 3J-10J.
Crossref
Crossref
Michael Aviram, Mira Rosenblat, Charles L Bisgaier & Roger S Newton. (1998) Atorvastatin and gemfibrozil metabolites, but not the parent drugs, are potent antioxidants against lipoprotein oxidation. Atherosclerosis 138:2, pages 271-280.
Crossref
Crossref
Kazuteru Oi & Hiromi Komori. (1998) Escape phenomenon with pravastatin during long-term treatment of patients with hyperlipidemia associated with diabetes mellitus. Current Therapeutic Research 59:2, pages 130-138.
Crossref
Crossref
Anders Lindahl, Rikard Sandström, Anna-Lena Ungell, Bertil Abrahamsson, Tina W. Knutson, Lars Knutson & Hans Lennernäs. (1996) Jejunal permeability and hepatic extraction of fluvastatin in humans. Clinical Pharmacology & Therapeutics 60:5, pages 493-503.
Crossref
Crossref
Pei‐Ming Shen, Ming‐Shi Shiao, Huey‐Ru Chung, Kuan‐Rong Lee, Yu‐Sheng Chao & Vincent M. Hunt. (2013) Liquid Chromatographic Determination of 3‐Hydroxy‐3‐methylglutaryl Coenzyme A Reductase Inhibitors. Journal of the Chinese Chemical Society 43:5, pages 451-457.
Crossref
Crossref
Reijo Laaksonen, Kalle Jokelainen, Timo Sahi, Matti J. Tikkanen & Jaakko-Juhani Himberg. (1995) Decreases in serum ubiquinone concentrations do not result in reduced levels in muscle tissue during short-term simvastatin treatment in humans*. Clinical Pharmacology & Therapeutics 57:1, pages 62-66.
Crossref
Crossref
Conrad B. Blum. (1994) Comparison of properties of four inhibitors of 3-hydroxy-3-methylglutaryl-coenzyme a reductase. The American Journal of Cardiology 73:14, pages D3-D11.
Crossref
Crossref
M. R. Soma, E. Donetti, C. Parolini, G. Mazzini, C. Ferrari, R. Fumagalli & R. Paoletti. (1993) HMG CoA reductase inhibitors. In vivo effects on carotid intimal thickening in normocholesterolemic rabbits. Arteriosclerosis, Thrombosis, and Vascular Biology 13:4, pages 571-578.
Crossref
Crossref
Shuet-Hing Lee Chiu. (1993) The use of in vitro metabolism studies in the understanding of new drugs. Journal of Pharmacological and Toxicological Methods 29:2, pages 77-83.
Crossref
Crossref
Gerald S. Brenner, Dean K. Ellison & Michael J. Kaufman. 1992.
277
305
.
Thomas M.A. Bocan, Erika Ferguson, William McNally, Paul D. Uhlendorf, Sandra Bak Mueller, Peter Dehart, Drago R. Sliskovic, Bruce D. Roth, Brian R. Krause & Roger S. Newton. (1992) Hepatic and nonhepatic sterol synthesis and tissue distribution following administration of a liver selective HMG-CoA reductase inhibitor, CI-981: Comparison with selected HMG-CoA reductase inhibitors. Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism 1123:2, pages 133-144.
Crossref
Crossref
Regina W. Wang, Prasad H. Kari, Anthony Y.H. Lu, Paul E. Thomas, F.Peter Guengerich & Kamlesh P. Vyas. (1991) Biotransformation of lovastatin. Archives of Biochemistry and Biophysics 290:2, pages 355-361.
Crossref
Crossref